These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39247216)

  • 1. Development of the sickle Pan-African research consortium registry in Tanzania: opportunity to harness data science for sickle cell disease.
    Kandonga D; Sangeda RZ; Masamu U; Kazumali E; Jonathan A; Msangawale M; Kaihula W; Rwegalulila J; Ondego J; Tutuba HJ; Ndunguru J; Ambrose EE; Kidenya BR; Yonazi M; Kyomugisha I; Mupfururirwa W; Jonas M; Nembaware V; Mazandu GK; Kengne AP; Wonkam A; Makani J; Balandya E
    Front Hematol; 2023; 2():. PubMed ID: 39247216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ugandan sickle Pan-African research consortium registry: design, development, and lessons.
    Nsubuga M; Mutegeki H; Jjingo D; Munube D; Namazzi R; Opoka R; Kasirye P; Ndeezi G; Hume H; Mupere E; Kebirungi G; Birungi I; Morrice J; Jonas M; Nembaware V; Wonkam A; Makani J; Kiguli S
    BMC Med Inform Decis Mak; 2024 Jul; 24(1):212. PubMed ID: 39075479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana.
    Paintsil V; Amuzu EX; Nyanor I; Asafo-Adjei E; Mohammed AR; Yawnumah SA; Oppong-Mensah YG; Nguah SB; Obeng P; Dogbe EE; Jonas M; Nembaware V; Mazandu G; Ohene-Frempong K; Wonkam A; Makani J; Ansong D; Osei-Akoto A;
    Front Genet; 2022; 13():802355. PubMed ID: 35281803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing a database for sickle cell disease patient mapping and survival tracking: The sickle pan-african research consortium Nigeria example.
    Nnodu O; Madu A; Chianumba R; Isa HA; Olanrewaju I; Osagie S; Oyekanmi N; Sangeda RZ; Stewart A; Nembaware V; Morrice J; Jonas M; Mazandu G; Wonkam A; Owolabi O
    Front Genet; 2022; 13():1041462. PubMed ID: 36406113
    [No Abstract]   [Full Text] [Related]  

  • 5. Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database.
    Isa H; Adegoke S; Madu A; Hassan AA; Ohiaeri C; Chianumba R; Brown B; Okocha E; Ugwu N; Diaku-Akinwumi I; Adeyemo T; Kuliya-Gwarzo A; Dogara L; Lawal H; Tanko Y; Ladu A; Kangiwa U; Ekwem L; Oniyangi S; Wakama T; Umoru D; Olanrewaju O; Akinola N; Nnebe-Agumadu U; Asala S; Adekile A; Olaniyi J; Sangeda R; Sickle Africa Data Coordinating Center SADaCC ; Nnodu O
    Blood Cells Mol Dis; 2020 Sep; 84():102438. PubMed ID: 32504882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skills Capacity Building For Health Care Services and Research Through the Sickle Pan African Research Consortium.
    Nnodu OE; Osei-Akoto A; Nembaware V; Kent J; Nwegbu M; Minja I; Mazandu GK; Makani J; Wonkam A
    Front Genet; 2022; 13():805806. PubMed ID: 35783259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing a Multi-Country Sickle Cell Disease Registry in Africa: Ethical Considerations.
    Munung NS; Nembaware V; de Vries J; Bukini D; Tluway F; Treadwell M; Sangeda RZ; Mazandu G; Jonas M; Paintsil V; Nnodu OE; Balandya E; Makani J; Wonkam A
    Front Genet; 2019; 10():943. PubMed ID: 31649726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica.
    Brown BJ; Madu A; Sangeda RZ; Nkya S; Peprah E; Paintsil V; Mmbando BP; Gyamfi J; Okocha CE; Asala SA; Nembaware V; Jonas M; Kengne AP; Chimusa ER; Nguweneza A; Isa HA; Nnebe-Agumadu U; Adekile AD; Osei-Akoto A; Ohene-Frempong K; Balandya E; Nnodu OE; Wonkam A; Makani J;
    Hemoglobin; 2021 May; 45(3):163-170. PubMed ID: 34355623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curative options for sickle cell disease in Africa: Approach in Tanzania.
    Makani J;
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):66-70. PubMed ID: 32201150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of Hydroxyurea Use in SCD and Evaluation of Patients' Perception and Experience in Nigeria.
    Chianumba RI; Ofakunrin AOD; Morrice J; Olanrewaju O; Oniyangi O; Kuliya-Gwarzo A; Nnebe-Agumadu U; Isa HA; Nnodu OE
    Front Genet; 2022; 13():826132. PubMed ID: 35401653
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of multi-level standards of care recommendations for sickle cell disease: Experience from SickleInAfrica.
    Paintsil V; Ally M; Isa H; Anie KA; Mgaya J; Nkanyemka M; Nembaware V; Oppong-Mensah YG; Ndobho F; Chirande L; Makubi A; Nnodu O; Wonkam A; Makani J; Ohene-Frempong K
    Front Genet; 2022; 13():1052179. PubMed ID: 36712852
    [No Abstract]   [Full Text] [Related]  

  • 12. Hospitalizations among children with sickle cell disease enrolled in the Kumasi Sickle Cell Pan African Consortium (SPARCo) database: A cross sectional study.
    Oppong-Mensah YG; Odoom SF; Nyanor I; Amuzu EX; Yawnumah SA; Asafo-Adjei E; Nguah SB; Ansong D; Osei-Akoto A; Paintsil V
    Health Sci Rep; 2023 Sep; 6(9):e1534. PubMed ID: 37670846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Rankine-Mullings AE; Nevitt SJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
    Nkya S; Mtei L; Soka D; Mdai V; Mwakale PB; Mrosso P; Mchoropa I; Rwezaula S; Azayo M; Ulenga N; Ngido M; Cox SE; D'Mello BS; Masanja H; Kabadi GS; Mbuya F; Mmbando B; Daniel Y; Streetly A; Killewo J; Tluway F; Lyimo M; Makani J
    Int Health; 2019 Nov; 11(6):589-595. PubMed ID: 31145786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Publication of data collection forms from NHLBI funded sickle cell disease implementation consortium (SCDIC) registry.
    Glassberg JA; Linton EA; Burson K; Hendershot T; Telfair J; Kanter J; Gordeuk VR; King AA; Melvin CL; Shah N; Hankins JS; Epié AY; Richardson LD;
    Orphanet J Rare Dis; 2020 Jul; 15(1):178. PubMed ID: 32635939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell disease in the Zanzibar Archipelago, the Republic of Tanzania.
    Richert W; Atumani MO; Kołodziej D; Korzeniewski K
    Int Marit Health; 2024; 75(1):43-48. PubMed ID: 38647058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ten year review of the sickle cell program in Muhimbili National Hospital, Tanzania.
    Makani J; Tluway F; Makubi A; Soka D; Nkya S; Sangeda R; Mgaya J; Rwezaula S; Kirkham FJ; Kindole C; Osati E; Meda E; Snow RW; Newton CR; Roberts D; Aboud M; Thein SL; Cox SE; Luzzatto L; Mmbando BP
    BMC Hematol; 2018; 18():33. PubMed ID: 30459954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
    Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
    MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
    Eastburg L; Peckham A; Kawira E; Chirangi B; Adler D; Akungo BD; Smart LR; Ambrose EE
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.